Literature DB >> 32677056

Development of anti-influenza agents from natural products.

Zhi-Jun Zhang1, Susan L Morris-Natschke2, Yung-Yi Cheng2, Kuo-Hsiung Lee2,3, Rong-Tao Li1.   

Abstract

The influenza pandemic continues to threaten public health due to its high morbidity and mortality rates, despite some successes in antiviral research. Natural drugs are important alternative therapies in the treatment of and recovery from influenza and have been the subjects of intense investigation during the last few decades. Many reports have shown that the development of novel bioactive chemicals extracted from natural drugs has significant advantages. Oseltamivir is a successful case of an anti-influenza drug synthesized using two natural products, quinic acid, and shikimic acid, as starting materials. In China, traditional Chinese medicine (TCM) plays an important role in the treatment of influenza. TCM herbal extracts and prescriptions or their isolated bioactive constituents have shown significant therapeutic and preventive effects against influenza. For example, the roots of Isatis indigotica (Banlangen) fight viral infection by targeting both the virus and the host and have significantly different effects than those of synthetic chemicals. Lianhuaqingwen capsule exerts its anti-influenza activity by regulating the immune response to interfere with both viral and host reactions and might well be an alternative therapeutic option to treat influenza virus infection. This paper reviews the chemical ingredients, crude extracts, and TCM prescriptions with anti-influenza activity reported during the period of 2010-September 2019. We hope that this comprehensive review will not only fuel research on anti-influenza active natural products and TCM research but also provide a promising alternative candidate for further anti-influenza drug development.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  TCM prescriptions; anti-influenza agents; medicinal plants; natural products

Year:  2020        PMID: 32677056     DOI: 10.1002/med.21707

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  8 in total

1.  Network pharmacology study on the mechanism of the Chinese medicine Radix Isatidis (Banlangen) for COVID-19.

Authors:  Bin Yu; Fei Lin; Hong Ning; Baodong Ling
Journal:  Medicine (Baltimore)       Date:  2021-08-13       Impact factor: 1.817

2.  Research progress on antiviral constituents in traditional Chinese medicines and their mechanisms of action.

Authors:  Zhi Chen; Si-Yong Ye
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

3.  (-)-Lariciresinol Isolated from the Roots of Isatis indigotica Fortune ex Lindl. Inhibits Hepatitis B Virus by Regulating Viral Transcription.

Authors:  Lu Yang; Huiqiang Wang; Haiyan Yan; Kun Wang; Shuo Wu; Yuhuan Li
Journal:  Molecules       Date:  2022-05-18       Impact factor: 4.927

4.  Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts.

Authors:  Zhonglei Wang; Liyan Yang
Journal:  J Ethnopharmacol       Date:  2021-01-21       Impact factor: 5.195

Review 5.  Chinese herbal injections for coronavirus disease 2019 (COVID-19): A narrative review.

Authors:  Xiao-Bin Zhu; Meng Guo; Zhi-Hui Zhang; Li-Hua Sun; Lei Liu; Li-Juan Zhou; Chun-Lei Shan; Yi Yang; Lian-Di Kan; Liu-Cheng Li
Journal:  Integr Med Res       Date:  2021-09-30

6.  Traditional Chinese Medicine Injections Combined With Oseltamivir for Influenza: Systematic Review and Network Meta-Analysis.

Authors:  Yingying Peng; Zhe Chen; Huanmin Li; Yaowei Han; Dan Sun; Yanjiao Li; Xiaoxia Wu; Hongxiang Chen; Xinmin Li
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

Review 7.  The efficacy and safety of combined chinese herbal medicine and western medicine therapy for COVID-19: a systematic review and meta-analysis.

Authors:  Lu Li; Hongliang Xie; Ling Wang; Aolin Zhang; Xuan Mou; Yifan Lin; Hongli Ma; Yu Wang; Jian Li; Jingshu Gao; Chi Chiu Wang; Ping Chung Leung; Xiaohui Fan; Xiaoke Wu
Journal:  Chin Med       Date:  2022-06-21       Impact factor: 4.546

Review 8.  Antiviral Drug Delivery System for Enhanced Bioactivity, Better Metabolism and Pharmacokinetic Characteristics.

Authors:  Ran Chen; Tingting Wang; Jie Song; Daojun Pu; Dan He; Jianjun Li; Jie Yang; Kailing Li; Cailing Zhong; Jingqing Zhang
Journal:  Int J Nanomedicine       Date:  2021-07-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.